Project Grant R03DE034794
Award Date
4/1/25
Completion Date
3/31/27
Dollars Obligated
$178K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award, titled "ROLE OF ICP0 DIMERIZATION IN HERPES SIMPLEX VIRUS PATHOGENESIS", is funded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) in the amount of $381,486. The award period runs from July 1, 2024 to May 31, 2026.
The primary objective of this research project is to identify the mechanisms by which the Herpes Simplex Virus (HSV) Infected Cell Protein 0 (ICP0) binds to itself to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the University of Arizona. This $118,763 award, effective September 1, 2024 through August 31, 2026, will support Dr. Robert Jackson's research on characterizing human papillomavirus (HPV) type 16 infections in oral epithelial tissues. The research aims to assess transformative versus productive viral lifecycles within tonsillar...
This federal Project Grant award from the National Institutes of Health (NIH), under the Trans-NIH Research Support (CFDA 93.310) program, provides $1,367,863 to Emory University to conduct biophysical research on herpesvirus capsid assembly and genome packaging. The goal is to develop new methodologies to monitor these essential viral processes in real-time, which could lead to a more complete understanding of herpesviral replication and the development of improved preventative and...
This Project Grant award of $155,500 from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports a comprehensive examination of the oral virome and its interactions with the oral microbiome. The research aims to mine existing metagenomic and metatranscriptomic datasets to shed light on the role of viruses in maintaining oral health and contributing to disease. The findings have the potential to inform...
This federal Project Grant award worth $474,407.00, issued by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research into the molecular mechanisms behind the antiviral defense response triggered by the cellular protein PML during herpes simplex virus (HSV) infection.
The research aims to identify the specific PML domains and DNA-binding capabilities required for PML nuclear body formation and...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $576,681 Cooperative Agreement under the Oral Diseases and Disorders Research (CFDA 93.121) program to Battelle Memorial Institute's Pacific Northwest National Laboratory Division. The grant supports the development of enhanced computational tools and methods to enable better detection, characterization, and visualization of viral elements within the human microbiome. This research aims to improve understanding of...
This $241,500 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, aims to identify diffusible small molecules that regulate the replication of the bacterial pathogen Porphyromonas gingivalis (P. gingivalis). The research seeks to determine the identity of growth-promoting cues produced by different strains of P. gingivalis and the bacterium Veillonella parvula that can...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $923,013 to the University of Southern California (USC) to target the UL37 deamidase enzyme in order to impede Herpes Simplex Virus-1 (HSV-1) infection. The research aims to identify inhibitors of the UL37 deamidase, which the virus uses to suppress the host's innate immune response. By characterizing the mode of action of these UL37...
This $478,800 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support the development of a new class of small molecules to induce protein phosphorylation. The award recipient, The Broad Institute, Inc., will work to create "phosphorylation editing chimeras" that use kinase inhibitors to recruit and activate kinases to phosphorylate target proteins on demand. This research aims to advance...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $162,216 to The Forsyth Institute, a non-profit research organization, from June 10, 2024 to May 31, 2026.
The project aims to investigate microbe-microbe interactions in the oral microbiome at the single-cell level using a combination of expansion microscopy and multiplex FISH imaging. This will allow the...